One Health, Vaccines and Ebola: The Opportunities for Shared Benefits

Journal of Agricultural and Environmental Ethics

Volumn 28, Issue 6, 2015, Pages 1011-1032

  Capps, Benjamin ^a   Lederman, Zohar ^b,c  

^a DALHOUSIE UNIVERSITY   (Canada)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Ebola virus; Immunity; One Health; Shared benefit; Vaccine; Zoonoses

Indexed keywords

DISEASE SPREAD; IMMUNITY; PRIMATE; PUBLIC HEALTH; VACCINATION; VACCINE; VIRAL DISEASE; VIRUS;

WEST AFRICA;

EBOLA VIRUS; HOMINIDAE;

EID: 84948380758     PISSN: 11877863     EISSN: 1573322X     Source Type: Journal    
DOI: 10.1007/s10806-015-9574-7     Document Type: Article

References (82)

1. Agnandji, S., Huttner, A., Zinser, M., et al. (2014). Phase 1 trials of rVSV Ebola vaccine in Africa and Europe—Preliminary report. New England Journal of Medicine. doi:10.1056/NEJMoa1502924.
2. Allouche, J. (2015). Ebola and extractive industry, IDS practice paper in brief 21. Brighton: Institute of Developmental Studies.
3. American Anthropological Society (AAA). (2014). Strengthening West African health care systems to stop Ebola: Anthropologists offer insights. Prepared November 18, 2014. Arlington, Virginia: AAA.
4. Associated Press. (2014, October 9). Excalibur, Spanish Ebola patient’s dog, is euthanised despite global outcry. The Guardian.
5. Bausch, D., & Schwarz, L. (2014). Outbreak of Ebola virus disease in Guinea: Where ecology meets economy. PLoS Neglected Tropical Diseases,8, e3056. doi:10.1371/journal.pntd.0003056.
6. Bermejo, M., Rodriguez-Teijeiro, J., Illera, G., et al. (2006). Ebola outbreak killed 5000 gorillas. Science,314, 1564.
7. Blaney, J., Wirblich, C., Papaneri, A., et al. (2011). Inactivated or live-attenuated bivalent vaccines that confer protection against rabies and Ebola viruses. Journal of Virology,85, 10605–10616.
8. Capps, B. (2013). Defining variables of access to UK Biobank: The public interest and the public good. Law, Innovation and Technology, 5, 113–139.
9. Capps, B., Bailey, M., Bickford, D., et al. (2015). Introducing One Health to the ethical debate about zoonotic diseases in South East Asia. Bioethics,29, 588–596.
10. Capps, B., & Lederman, Z. (2015). One Health and paradigms of public biobanking. Journal of Medical Ethics, 41, 258–262.
11. Capps, B., & Lysaght, T. (2013). Challenging the production of vaccines for a future influenza pandemic. Asian Bioethics Review, 5, 110–130.
12. Cardinale, B., Duffy, J., Gonzales, A., et al. (2012). Biodiversity loss and its impact on humanity. Nature,486, 59–67.
13. Chan, M. (2014). WHO Director-General addresses the Regional Committee for Africa; Director-General of the World Health Organization; Address to the Regional Committee for Africa, Sixty-fourth Session; Cotonou, Republic of Benin; 3 November 2014.
14. Conniff, R. (2014). Useless creatures. New York Times, September 14: SR8.
15. Dawson, A. (2014). Ebola: What it tells us about medical ethics. Journal of Medical Ethics,41, 107–110.
16. Donovan, G. (2014). Ebola, epidemics, and ethics—What we have learned. Philosophy, Ethics, and Humanities in Medicine. doi:10.1186/1747-5341-9-15.
17. Epstein, P. (2001). Climate change and emerging infectious diseases. Microbes and Infection,3, 747–754.
18. Escudero-Perez, B., Volchkova, V., Dolnik, O., et al. (2014). Shed GP of Ebola virus triggers immune activation and increased vascular permeability. PLoS ONE,10, e1004509.
19. Faria, N., Rambaut, A., Suchard, M., et al. (2014). The early spread and epidemic ignition of HIV-1 in human populations. Science,346, 56–61.
20. Farmer, P. (2014). Diary. London Review of Books,36, 38–39.
21. Feldmann, H., & Geisbert, T. (2011). Ebola haemorrhagic fever. The Lancet,277, 849–862.
22. Fenton, A. (2014). Can a chimp say “No”? Reenvisioning chimpanzee dissent in harmful research. Cambridge Quarterly of Healthcare Ethics,23, 130–139.
23. Fjeldsæter, A. (2014, July 17). Ebola in Sierra Leone: Battling sadness, fear and disgust on the frontline. The Guardian.
24. Garrett, L. (1995). The coming plague: Newly emerging diseases in a world out of balance. London: Penguin Books.
25. Gates, B. (2015). The next epidemic—Lessons from Ebola. The New England Journal of Medicine,372, 1381–1384.
26. Geisbert, T., & Feldmann, H. (2011). Recombinant vesicular stomatitis virus-based vaccines against Ebola and Marburg virus infections. Journal of Infectious Diseases,204, s1075–s1081.
27. Genton, C., Plerre, A., Cristescu, R., et al. (2014). How Ebola impacts social dynamics in gorillas: A multistate modeling approach. Journal of Animal Ecology. doi:10.1111/1365-2656.12268.
28. Harris, N., & Dunn, R. (2013). Species loss on spatial patterns and composition of zoonotic parasites. Proceedings of the Royal Society B,280, 20131847.
29. Hayden, E. (2014). The Ebola question. Nature News,514, 554–557.
30. Hayden, E. (2015). Biobank planned for Ebola samples. Nature,524, 147.
31. Hockings, K., McLennan, M., Carvalho, S., et al. (2015). Apes in the anthopocene: Flexibility and survival. Trends in Ecology & Evolution, 30, 215–222.
32. Jenkins, H., Woodroffe, R., & Donnelly, C. (2010). The duration of the effects of repeated widespread badger culling on cattle tuberculosis following the cessation of culling. PLoS ONE,5, e9090.
33. Johansen, M., & Penrith, M. (2009). Has culling been properly assessed as a valid and justified control intervention measure for zoonotic diseases? Neglected Tropical Diseases,3, e541.
34. Jones, K. (2008). Global trends in emerging infectious diseases. Nature,451, 990–994.
35. Kahn, L. H., Kaplan, B., & Steele, J. H. (2007). Confronting zoonosis through closer collaboration between medicine and veterinary medicine (as ‘One Medicine’). Veterinaria Italiana, 43, 5–19.
36. Kahn, S., Geale, D., Kitching, P., et al. (2002). Vaccination against foot-and-mouth disease: The implications for Canada. Canadian Veterinary Journal,43, 349–354.
37. Kaiser, J. (2003). Ebola, hunting push ape populations to the brink. Science,300, 232.
38. Kangbai, J., & Koroma, M. (2015). Changing epidemiology of West Africa Ebola outbreaks 1994–2014. British Journal of Medicine & Medical Research,6, 538–546.
39. Keesing, F., Belden, L., Daszak, P., et al. (2010). Impacts of biodiversity on the emergence and transmission of infectious diseases. Nature,468, 647–652.
40. Köndgen, S., Kühl, H., N’Goran, P., et al. (2008). Pandemic human viruses cause decline of endangered great apes. Current Biology,18, 260–264.
41. Lapinski, M., Funk, J., & Moccia, L. (2015). Recommendations for the role of social science research in One Health. Social Science and Medicine,129, 51–60.
42. Leach, M., & Scoones, I. (2013). The social and political lives of zoonotic disease models: Narratives, science and policy. Social Science and Medicine,88, 10–17.
43. Looi, L., & Chua, K. (2007). Lessons from the Nipah virus outbreak. Journal of Pathology,29, 63–67.
44. MacNeil, A., & Rollin, P. (2012). Ebola and Marburg hemorrhagic fevers: Neglected tropical diseases? PLoS Neglected Tropical Diseases,6, e1546.
45. Mark, M. (2014, July 3). Fear and ignorance as Ebola ‘Out of Control’ in parts of West Africa. The Guardian.
46. Marzi, A., & Feldmann, H. (2014). Ebola virus vaccines: An overview of current approaches. Expert Review of Vaccines,13, 521–531.
47. Middleton, D., Pallister, J., Klein, R., et al. (2014). Hendra virus vaccine, a One Health approach to protecting horse, human, and environmental health. Emerging Infectious Disease. doi:10.3201/eid2003.131159.
48. Mitman, G. (2014). Ebola in a stew of fear. New England Journal of Medicine,371, 1763–1765.
49. Monath, T. (1999). Ecology of Marburg and Ebola viruses: Speculations and directions for future research. Journal of Infectious Disease,179(Supplement 1), S127–S138.
50. Morse, S. (2009). Emerging infections: Condemned to repeat? In Microbial evolution and co-adaptation: A tribute to the life and scientific legacies of Joshua Lederberg: Workshop summary. Institute of Medicine (US) Forum on Microbial Threats. Washington (DC): National Academies Press.
51. Morters, M., Restif, O., Hampson, K., et al. (2013). Evidence-based control of canine rabies: A critical review of population density reduction. Journal of Animal Ecology,82, 6–14.
52. Muyembe-Tamfum, J., Mulangu, S., Masumu, J., et al. (2012). Ebola virus outbreaks in Africa: Past and present. Onderstepoort Journal of Veterinary Research,79, 451.
53. Neyland, D. (2013). An Ethnography of Numbers. In D. Caulkins & T. Jordan (Eds.), A companion to organizational anthropology (1st ed., pp. 219–235). London: Blackwell Publishing.
54. Nkoghe, D., Padilla, C., Becquart, P., et al. (2011). Risk factors for Zaire ebolavirus–specific IgG in rural Gabonese populations. Journal of Infectious Disease,204(Suppl 3), S768–S775.
55. Olival, K., & Hayman, D. (2014). Filoviruses in bats: Current knowledge and future directions. Viruses,6, 1759–1788.
56. Olson, S., Reed, P., Cameron, K., et al. (2012). Dead or alive: Animal sampling during Ebola hemorrhagic fever outbreaks in humans. Emerging Health Threats Journal. doi:10.3402/ehtj.v5i0.9134.
57. Pedersen, A., & Davies, T. (2009). Cross-species pathogen transmission and disease emergence in primates. Journal of Ecohealth,6, 496–508.
58. Potter, V. R. (1988). Global bioethics. East Lansing: Michigan State University Press.
59. Quammen, D. (2015). The chimp and the river: How AIDS emerged from an African forest. New York: W. W. Norton & Company.
60. Rabinowitz, P., Kock, M., Kachani, M., et al. (2013). Toward proof of concept of a One Health approach to disease prediction and control. Emerging Infectious Diseases,19, e130265.
61. Rabinowitz, P., Odofin, M., & Dein, J. (2008). From “Us vs. Them” to “Shared Risk”: Can animals help link environmental factors to human health? EcoHealth,5, 224–229.
62. Rampling, T., Ewer, K., Bowyer, G., et al. (2015). A monovalent chimpanzee adenovirus Ebola vaccine-Preliminary report. New England Journal of Medicine. doi:10.1056/NEJMoa1411627.
63. Rid, A., & Emanuel, E. (2014). Ethical considerations of experimental interventions in the Ebola outbreak. The Lancet,384, 1896–1899.
64. Rio, C., Mehta, A., Lyon, M., & Guarner, J. (2014). Ebola hemorrhagic fever in 2014: The tale of an evolving epidemic. Annals of Internal Medicine,161, 746–748.
65. Ryan, S., & Walsh, P. (2011). Consequences of non-intervention for infectious disease in African great apes. PLoS,6, e29030.
66. Saéz, A., Weiss, S., Nowak, K., et al. (2014). Investigating the zoonotic origin of the West African Ebola epidemic. EMBO Molecular Medicine,7, 17–23.
67. Scoones, I. (2010). Towards a One World, One Health approach. In I. Scoone (Ed.), Avian influenza: Science, policy and politics. London: Earthscan.
68. Shaw, D. (2014). Randomisation is essential in Ebola drug trials. The Lancet. doi:10.1016/S0140-6736(14)61735-9.
69. Spencer, C. (2015). Having and fighting Ebola—Public health lessons from a clinician turned patient. New England Journal of Medicine,372, 1089–1091.
70. Stanley, D., Honko, A., Asiedu, C., et al. (2014). Chimpanzee adenovirus vaccine generates acute and durable protective immunity against Ebolavirus challenge. Nature Medicine,20, 1126–1129.
71. Thompson, P., & List, M. (2015). Ebola needs One Bioethics. Ethics, Policy & Environment,18, 96–102.
72. Towner, J., Amman, B., Sealy, T., et al. (2009). Isolation of genetically diverse Marburg viruses from Egyptian fruit bats. PLoS Pathology,5, e10000212.
73. Walsh, P., Abernethy, K., Bermejo, M., et al. (2003). Catastrophic ape decline in western equatorial Africa. Nature,422, 611–614.
74. Walsh, P., Breuer, T., Sanz, C., et al. (2007). Potential for Ebola transmission between gorilla and chimpanzee social groups. American Naturalist,169, 684–689.
75. Warfield, K., Goetzmann, J., Biggins, J., et al. (2014). Vaccinating captive chimpanzees to save wild chimpanzees. Proceedings of the National Academies of Science,111, 8873–8876.
76. Wendler, D. (2014). Should protections for research with humans who cannot consent apply to research with nonhuman primates? Theoretical Medicine and Bioethics,35, 157–173.
77. WHO. (2014). Ebola situation in Liberia: non-conventional interventions needed. Ebola situation assessment 8 September. http://www.who.int/mediacentre/news/ebola/8-september-2014/en/.
78. WHO. (2015). Second WHO high-level meeting on Ebola vaccines access and financing. Summary report. WHO/EVD/Meet/HIS/15.1.
79. WHO Ebola Response Team. (2015). West African Ebola epidemic after one year-slowing but not yet under control. New England Journal of Medicine,372, 584–587.
80. Wolfe, N., Daszak, P., Marm Kilpatrick, A., & Burke, D. (2005). Bushmeat hunting, deforestation, and prediction of zoonotic disease. Emerging Infectious Disease,11, 1822–1827.
81. Yakubu, A., Oluwatoyin, M., Sani-Gwarzo, N., et al. (2014). The Ebola outbreak in Western Africa: Ethical obligations for care. Journal of Medical Ethics. doi:10.1136/medethics-2014-102434.
82. Yeates, J. (2013). Animal welfare in veterinary practice. Chichester: Wiley-Blackwell.